Two different STAT1 gain-of-function mutations lead to diverse IFN-γ-mediated gene expression

• Published in: Npj genomic medicine Vol. 3; no. 1; pp. 23 - 5
• Main Authors: Ovadia, Adi, Sharfe, Nigel, Hawkins, Cynthia, Laughlin, Suzanne, Roifman, Chaim M.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 20.08.2018; Nature Publishing Group
• Subjects: 692/4017; 692/699; Bioinformatics; Biomedical and Life Sciences; Biomedicine; Case Report; Gene expression; Gene Function; Gene Therapy; Human Genetics; Internal Medicine; Kinases; Mutation
• ISSN: 2056-7944; 2056-7944
• DOI: 10.1038/s41525-018-0063-6

Signal transducer and activator of transcription 1 (STAT1) regulates multiple biological processes downstream of a variety of cytokine receptors in many cell types. Heterozygous gain-of-function (GOF) mutations in STAT1 have been associated with a diverse phenotype encompassing chronic mucocutaneous candidiasis (CMCC) and declining immunity. There is no clear correlation between STAT1 domain-specific mutations and phenotype, and it remains unclear why GOF mutations in STAT1 result in such a wide spectrum of clinical presentations. To begin exploring this dilemma, we have studied the patterns of gene expression mediated by two different GOF mutations. Analysis of IFN-γ response elements using RNA microarrays in cells transfected with the rare H629Y mutant or the common R274G mutant showed distinct patterns of gene expression. We show here that the impact of GOF mutations in STAT1 is variant-specific. This difference in gene expression may explain the diversity in clinical manifestations experienced by these patients.